Matthias is a bioprocessing leader driven by one central question: why do so many breakthrough therapies fail not because of science, but because of manufacturing? Trained in virology and molecular biology, he spent over 15 years in biotech translating innovation into clinical reality. At Themis Bioscience, he built and led Technical Operations and helped bring vaccine programs from early research into clinical development. After witnessing repeated CMC bottlenecks slow down promising therapies, he co-founded bespark*bio to rethink how bioprocessing is approached. His work focuses on combining deep industrial know-how with data modeling and digital tools to drastically reduce experimental burden and make development more predictive. His mission: to transform bioprocessing from trial-and-error into a data-driven discipline. So life-changing therapies reach patients faster and more reliably."